Kezar Life Sciences's market cap is currently $46.72M. The company's EPS TTM is $-13.152; its P/E ratio is ―; Kezar Life Sciences is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-2.72. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 7.00M	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 5.93M	$ -1.02M	$ -1.51M	$ -1.54M	$ -1.30M
Operating Income	$ -105.24M	$ -71.16M	$ -54.66M	$ -42.95M	$ -37.34M
EBITDA	$ -99.25M	$ -66.11M	$ -52.96M	$ -40.26M	$ -34.42M
Net Income	$ -101.87M	$ -65.32M	$ -53.28M	$ -38.99M	$ -31.53M
Balance Sheet
Cash & Short-Term Investments	$ 201.37M	$ 276.56M	$ 208.35M	$ 140.45M	$ 78.21M
Total Assets	$ 221.24M	$ 299.57M	$ 217.93M	$ 151.84M	$ 89.51M
Total Debt	$ 18.93M	$ 21.26M	$ 14.04M	$ 5.46M	$ 6.36M
Net Debt	$ -16.56M	$ -19.19M	$ -48.84M	$ -15.76M	$ -8.59M
Total Liabilities	$ 33.66M	$ 29.70M	$ 21.06M	$ 10.86M	$ 11.47M
Stockholders' Equity	$ 187.57M	$ 269.87M	$ 196.88M	$ 140.98M	$ 78.05M
Cash Flow
Free Cash Flow	$ -83.45M	$ -60.42M	$ -42.75M	$ -37.14M	$ -30.48M
Operating Cash Flow	$ -81.64M	$ -58.85M	$ -42.44M	$ -36.95M	$ -29.88M
Investing Cash Flow	$ 76.05M	$ -91.39M	$ -28.44M	$ -56.50M	$ 20.42M
Financing Cash Flow	$ 638.00K	$ 127.86M	$ 112.58M	$ 99.64M	$ 272.00K

Currency in USD

Kezar Life Sciences Earnings and Revenue History

Income Statement >

Kezar Life Sciences Debt to Assets

Balance Sheet >

Kezar Life Sciences Cash Flow

Cash Flow >

Kezar Life Sciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing